ArticleInflammation2026
Erosion or Explosion: Integrated Single-Cell Transcriptomics Reveals Cellular Heterogeneity in Aortic Aneurysm and Dissection.
Article in Inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aortic aneurysm (AA) and aortic dissection (AD) are life-threatening vascular diseases characterized by progressive wall degeneration and structural failure. However, the cellular mechanisms underlying their progression and rupture remain poorly understood. We performed integrative single-cell RNA sequencing analysis on four human aortic datasets, including thoracic aortic dissection (TAD), thoracic aortic aneurysm (TAA), abdominal aortic aneurysm (AAA), and ruptured AAA. We identified disease-specific patterns of immune infiltration and vascular structural cell loss. Vascular smooth muscle cells (VSMCs) and endothelial cells (ECs) were reduced in AA but increased in AD. In ruptured AAA, structural cells were nearly absent, with immune cells predominating. In TAD, VSMCs and ECs exhibited marked phenotypic plasticity, transdifferentiating into multiple cell subtypes. Notably, we identified macrophage-like VSMCs and ECs in AD mouse models. Cell-cell communication analysis revealed that macrophages communicated with VSMCs and ECs via the CXCL, IL1B, and SPP1 signaling axes. Importantly, REL, a member of the NF-κB transcription factor family, was identified as a convergent node integrating these inflammatory signals. This study delineates disease-specific transdifferentiation trajectories of ECs and VSMCs during AA and AD progression. Inflammatory macrophages regulate this phenotypic switching via CXCL, IL1B, and SPP1 signaling, activating REL-driven transcriptional programs that compromise vascular integrity. These findings uncover fundamental differences in cellular heterogeneity and injury mechanisms between AA and AD, offering potential therapeutic targets for preventing disease progression and rupture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.